This drug combination (12.5 μM lovastatin+5 nM docetaxel) also triggered apoptosis in other cell types, including HepG2 human hepatoblastoma, HeLa cervical cancer, and H322 lung cancer cells, as demonstrated by increased caspase 3/7 activity (Supplementary Figure 2). This evidence concerns the gene CASP3 and lung carcinoma.